Slideshows Images Quizzes

Auralgan

Last reviewed on RxList: 12/8/2004
Drug Description

Auralgan
(antipyrine, benzocaine, and dehydrated glycerin)

DESCRIPTION

Each mL contains:

Antipyrine  ............................................ 54.0 mg

Benzocaine ........................................... 14.0 mg

Glycerin dehydrated q.s. to ..................... 1.0 mL

(contains not more than 0.6% moisture)
 (also contains oxyquinoline sulfate)

TOPICAL DECONGESTANT AND ANALGESIC

Auralgan is an otic solution containing antipyrine, benzocaine, and dehydrated glycerin. The solution congeals at 0° C (32° F), but returns to normal consistency, unchanged, at room temperature.

For Consumers

What are the precautions when taking antipyrine, benzocaine and glycerin dehydrated (Auralgan)?

Before using this medication, tell your doctor or pharmacist if you are allergic to antipyrine, benzocaine, or other ingredients in this product (e.g., glycerin, zinc acetate); or to other ester-type anesthetics (e.g., procaine, tetracaine); or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

This medication should not be used if you have certain medical conditions. Before using this medicine, consult your doctor or pharmacist if you have: hole in the eardrum (perforated tympanic membrane).

Before using this medication, tell your doctor or pharmacist your medical history, especially of: ear injuries/surgery.

During pregnancy, this medication...

Indications & Dosage

INDICATIONS

ACUTE OTITIS MEDIA OF VARIOUS ETIOLOGIES

prompt relief of pain and reduction of inflammation in the congestive and serous stages

adjuvant therapy during systemic antibiotic administration for resolution of the infection

Because of the close anatomical relationship of the eustachian tube to the nasal cavity, otitis media is a frequent problem, especially in children in whom the tube is shorter, wider, and more horizontal than in adults.

REMOVAL OF CERUMEN

facilitates the removal of excessive or impacted cerumen

DOSAGE AND ADMINISTRATION

ACUTE OTITIS MEDIA

Instill Auralgan (antipyrine, benzocaine and glycerin dehydrated) permitting the solution to run along the wall of the canal until it is filled. Avoid touching the ear with dropper. Then moisten a cotton pledget with Auralgan (antipyrine, benzocaine and glycerin dehydrated) and insert into meatus. Repeat every one to two hours until pain and congestion are relieved.

REMOVAL OF CERUMEN

Before:  Instill Auralgan (antipyrine, benzocaine and glycerin dehydrated) three times daily for two or three days to help detach cerumen from wall of canal and facilitate removal.
After:   Auralgan (antipyrine, benzocaine and glycerin dehydrated) is useful for drying out the canal or relieving discomfort.

Before and after removal of cerumen, a cotton pledget moistened with Auralgan (antipyrine, benzocaine and glycerin dehydrated) should be inserted into the meatus following instillation.

Note:  Do not rinse dropper after use.

Replace dropper in bottle after each use. Hold dropper assembly by screw cap and, without compressing the rubber bulb, insert into drug container and screw down tightly.

Protect the solution from light and heat, and do not use if it is brown or contains a precipitate.

DISCARD THIS PRODUCT SIX MONTHS AFTER DROPPER IS FIRST PLACED IN THE DRUG SOLUTION.

HOW SUPPLIED

Auralgan (antipyrine, benzocaine and glycerin dehydrated) ® Otic Solution, in package containing 10 mL bottle with separate dropper-screw cap attachment (NDC 0046-1000-10).

Store at room temperature (approximately 25° C).

Manufactured by:
Ayerst Laboratories Inc.
A Wyeth-Ayerst Company
Philadelphia, PA 19101

Side Effects & Drug Interactions

SIDE EFFECTS

No Information Provided.

DRUG INTERACTIONS

No Information Provided.

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Warnings & Precautions

WARNINGS

Discontinue promptly if sensitization or irritation occurs.

PRECAUTIONS

CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY

No long-term studies in animals or humans have been conducted

PREGNANCY CATEGORY C

Animal reproduction studies have not been conducted with Auralgan (antipyrine, benzocaine and glycerin dehydrated) . It is also not known whether Auralgan (antipyrine, benzocaine and glycerin dehydrated) can cause fetal harm when administered to a pregnant woman, or can affect reproduction capacity. Auralgan (antipyrine, benzocaine and glycerin dehydrated) should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Auralgan (antipyrine, benzocaine and glycerin dehydrated) is administered to a nursing woman.

Overdosage & Contraindications

OVERDOSE

No Information Provided.

CONTRAINDICATIONS

Hypersensitivity to any of the components or substances related to them.

Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

Clinical Pharmacology

CLINICAL PHARMACOLOGY

Auralgan (antipyrine, benzocaine and glycerin dehydrated) combines the hygroscopic property of dehydrated glycerin with the analgesic action of antipyrine and benzocaine to relieve pressure, reduce inflammation and congestion, and alleviate pain and discomfort in acute otitis media.

Auralgan (antipyrine, benzocaine and glycerin dehydrated) does not blanch the tympanic membrane or mask the landmarks and, therefore, does not distort the otoscopic picture.

Medication Guide

PATIENT INFORMATION

No Information Provided.

Health Solutions From Our Sponsors